Blood-feeding arthropods digest vast amounts of host-blood nutrients. A new study suggests that tyrosine degradation is essential for the survival of blood-fed kissing bugs, mosquitoes, and ticks. This finding presents a promising target for the control of these disease vectors.
Blood-feeding arthropods, such as mosquitoes, tse-tse flies, sand flies, kissing bugs, and ticks, transmit a broad variety of infectious diseases, which have a severe impact on human health and the agricultural economy worldwide [1] . According to the World Health Organization [2] , ''vector-borne diseases account for more than 17% of all infectious diseases, causing more than one million deaths annually.'' Diseases such as malaria, Chagas disease, leishmaniasis, Dengue fever, Lyme disease, schistosomiasis, sleeping sickness and, most recently, infections caused by the Zika virus affect hundreds of millions of people around the globe. Therefore, scientists from various research fields join forces in a common effort to find vulnerable targets to combat blood-feeding arthropods and the infections they transmit. Even though parasitic arthropods differ in many biological aspects, reflecting their independent evolutionary routes towards hematophagy (blood-feeding lifestyle), they all share one common trait -they all eat a lot! Can you imagine gorging yourself on food 100 times your own weight? Such gluttony would certainly kill the gourmands, as artistically portrayed in Marco Ferreri's classic film La Grande Bouffe. The reason why blood feeders eat as much as they do in a single blood meal is that blood feeding on the host is a risky maneuver, and a second opportunity to feed may not arise. Is there a common toolkit necessary for the successful digestion of such a large, nutrient-full meal? In this issue of Current Biology, Sterkel et al. [3] report on the discovery of the vital importance of functional tyrosine detoxification for blood-feeding arthropods [3] .
Early studies by the research group of Pedro Oliveira significantly contributed to our current knowledge of how hematophagous arthropods have adapted to their bloody diet, mainly focusing on heme-detoxification mechanisms [4, 5] . Heme, an ironcontaining pro-oxidative molecule, is a component of host hemoglobin, the major protein constituent of blood that enables oxygen transport in the body. Vast amounts of heme from digested hemoglobin present a serious challenge for blood-feeding arthropods. Kissing bugs of the genus Rhodnius were shown to make crystals of excessive heme in a hemozoin-like structure [6] . Mosquitoes break heme down into a distinct degradation product [7] . Ticks store excessive heme in an organelle-like compartment called the hemosome [8, 9] . As ticks lack heme biosynthesis [10] , a small portion of acquired heme is used for the assembly of their endogenous hemoproteins. Failure of heme acquisition and inter-tissue trafficking leads to aborted embryogenesis in ticks [11] . In addition to heme and iron metabolism, the tyrosine-degradation pathway now described by Sterkel et al. [3] reveals a novel Achilles' heel in the physiology of blood-feeding arthropods.
Tyrosine is a semi-essential amino acid that can be either synthesized from phenylalanine or directly acquired from the diet. Eukaryotic proteins, including blood proteins, are not particularly rich in tyrosine (about 3% of total amino acids). Yet previous tissue-specific transcriptomic analyses in Rhodnius prolixus revealed an over-representation of transcripts encoding enzymes involved in tyrosine degradation in the digestive tract [12] . In order to elucidate the physiological relevance of this finding, Sterkel et al. [3] performed a series of functional studies focused on enzymes participating in tyrosine metabolism. The tyrosine-degradation pathway consists of five enzymatic steps, each of which is catalyzed by a discrete protein encoded by a single gene. The authors performed RNAi-mediated silencing of all five genes, yet only the knockdown of those genes encoding tyrosine aminotransferase (TAT) and 4-hydroxyphenylpyruvate dioxygenase (HPPD), the first two enzymes in the tyrosine-catabolism pathway, resulted in a marked reduction of survival of R. prolixus females following a blood meal (Figure 1 ). The authors reasoned that the observed lethal phenotype was most likely caused by the formation of crystals resulting from the accumulation of tyrosine upon digestion of vast amounts of host blood. Such a mechanism may remotely resemble gout, the human disorder caused by excessive meat consumption that is manifested by formation of uric-acid crystal deposits in the joints.
The authors also examined the functions of other genes involved in alternative pathways of tyrosine metabolism, for example, prophenoloxidases or tyrosine hydroxylase. However, RNAi-mediated knockdown of these genes did not exert a similar killing effect as that observed for knockdown of TAT and HPPD [3] . This observation further corroborates the hypothesis that the accumulation of tyrosine, rather than the absence of a tyrosine-derived molecule, mediates the lethality associated with inhibition of the tyrosine-degradation pathway.
In addition to using RNAi, the authors took the advantage of the availability of specific HPPD inhibitors [13, 14] that are ordinarily used as a herbicide (mesotrione) or as a drug (nitisinone/ OrfadinÒ) taken by patients with hereditary tyrosinemia type I (a genetic defect in the tyrosine-degradation pathway). Mesotrione administered to R. prolixus either by injection or via artificial membrane feeding caused the premature death of blood-fed adult and nymphal stages of kissing bugs, similar to that observed following RNAimediated knockdown of the genes encoding TAT or HPPD. Moreover, further experiments demonstrated that inhibition of tyrosine degradation with mesotrione kills other blood-feeding disease vectors including Aedes aegypti or the cattle tick Rhipicephalus microplus (Figure 1 ). Most importantly, HPPD inhibition had no impact on two nonhematophagous insects studied, the milkweed bug (Oncopeltus fasciatus) and the mealworm beetle (Tenebrio molitor). These results substantiate the pivotal point of the study: impairing tyrosine degradation selectively kills bloodfeeding arthropods.
Additional experiments by Sterkel et al. [3] , oriented towards practical applications of their discovery, revealed that a mesotrione dose lethal for mature or immature kissing-bug stages could be absorbed through their cuticle via topical application, and that blood feeding on mice that had been administered nitisinone orally was also lethal. This signifies a fundamental prerequisite towards the development of novel insecticides based on HPPD inhibition. At present, over 6,000 HPPD inhibitors, with different chemical properties, have been developed in the search for a potent and environmentally friendly herbicide [13] . A systematic screening of appropriate candidates will be a useful starting point towards bringing the discovery of Sterkel et al. [3] to fruition in the development of a selective insecticide that specifically kills blood-feeding arthropods. Given that the phenotype is brought about only after a blood meal (Figure 1) Figure 1 . The essential nature of tyrosine detoxification in blood-feeding arthropods.
Blood-feeding arthropods such as (left to right) the kissing bug R. prolixus (Chagas-disease vector), the mosquito Ae. aegypti (vector of yellow fever and other infectious agents), and the cattle tick R. microplus, have to cope with vast amounts of nutrients acquired from a protein-rich blood meal. L-tyrosine, a semi-essential amino acid liberated upon digestion of host blood proteins, is further catabolized via a conserved pathway of five enzymatic steps. The first two enzymes of the tyrosinecatabolism pathway are tyrosine aminotransferase (TAT) and 4-hydroxyphenylpyruvate dioxygenase (HPPD). RNAi-mediated silencing of the gene encoding HHPD, or treatment with an HHPD inhibitor, is lethal for blood feeders due to the accumulation of crystals formed from an excess of non-degraded tyrosine. Image courtesy of Martina Hajduskova (www.biographix.cz).
What are the synaptic drives controlling the sleep-wake circuitry in the mammalian brain? In a new study it was found that GABAergic cells in posterior lateral hypothalamus inhibit sleep-promoting anterior hypothalamic cells to cause waking, whereas their inhibition augments sleep.
The movie 'Awakenings' (1990), starring Robert de Niro as a 40-year old encephalitis lethargica victim waking up after three decades of somnolence, is a captivating story of a life without control over sleep and wakefulness. This movie, adapted from the award-winning book of the late Oliver Sacks , undoubtedly selects a historically unique and dramatic case of human debilitation. However, remind yourself of the last day after an all-nighter to get a flavor of how life would be if sleep took over uncontrollably. Indeed, repeated intrusion of sleep into waking, as well as the converse, disruption of sleep by awakenings, often indicate a need for neurological consultation. These symptoms also bring to light an obvious, yet neurobiologically non-trivial, capability of our brain: it keeps sleep and wake strictly segregated and ensures that transitions occur rapidly, similar to on-off switches of the lights in our houses at day or night onset. A study in this issue of Current Biology, authored by Venner et al. [1] , presents a novel synaptic pathway through which this vital switch is made possible.
Neuroanatomic and lesioning studies for most of the past century have uncovered groups of neurons, located mainly in the brainstem and hypothalamus, that are implicated in vigilance state control [2] . Focusing here on waking and non-REM sleep, these fall broadly into wake-and non-REM sleep-active neuronal subgroups. Each increases action potential discharge during its preferred vigilance state and each receives dense inhibitory input from its counterpoised partner. Such a circuitry ensures rapid and complete state transitions: overcoming inhibition on one side leads to more inhibition on the antagonist side, reinforcing the winner's activity. A current influential working model of the sleep-wake switch is analogous to a 'flip-flop' electronic circuit. This is a bistable device that will remain in one state until a trigger causes it to switch to the other state [3] ( Figure 1A ). But which are the triggers of the transition? Multiple regulatory inputs arising from circadian, homeostatic and allostatic systems [3, 4] need to be coordinated to decide between sleep and wakefulness. Furthermore, limbic and cognitive variables modulate sleep-wake states. Little is known about the wiring of all these synaptic inputs into the sleep-wake switch. Do they conform to the flip-flop model proposing that sleep-wake transitions need synaptic excitation of wakepromoting groups, whereas sleeppromoting groups are excited for the reverse transition?
Optogenetic and chemogenetic techniques equip neurons with optic or ligand actuators such that light pulses or designer drugs control their electrical activity. These techniques are ideal to probe the sleep-wake control elements directly and to set their activity in causal relation with the vigilance state. Currently available studies have indeed successfully woken up sleeping mice, for example through illuminating hypothalamic orexinergic neurons [5] or brainstem noradrenergic neurons within the locus coeruleus (LC) [6] , corroborating the power of these wake-promoting cell types as part of the flip-flop model.
The optogenetic dissection of the sleep-promoting circuit, in contrast, is just about to start. A small cluster of neurons within the preoptic hypothalamus facing the bottom surface of the brain, the ventrolateral preoptic (VLPO) area, shows a strong increase in firing during sleep and densely innervates many wake-promoting brain areas [7] . The VLPO area has been a prominent element in the flip-flop
